Timothy R. Aksamit

12.2k total citations · 2 hit papers
90 papers, 6.9k citations indexed

About

Timothy R. Aksamit is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Timothy R. Aksamit has authored 90 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 42 papers in Epidemiology and 30 papers in Infectious Diseases. Recurrent topics in Timothy R. Aksamit's work include Cystic Fibrosis Research Advances (35 papers), Mycobacterium research and diagnosis (33 papers) and Tuberculosis Research and Epidemiology (26 papers). Timothy R. Aksamit is often cited by papers focused on Cystic Fibrosis Research Advances (35 papers), Mycobacterium research and diagnosis (33 papers) and Tuberculosis Research and Epidemiology (26 papers). Timothy R. Aksamit collaborates with scholars based in United States, United Kingdom and Australia. Timothy R. Aksamit's co-authors include David E. Griffith, Kevin Winthrop, Charles L. Daley, Barbara A. Brown‐Elliott, Richard J. Wallace, Kenneth N. Olivier, Stephen J. Ruoss, Antonino Catanzaro, Fred M. Gordin and Michael F. Iademarco and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Timothy R. Aksamit

83 papers receiving 6.8k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases

2007 4.3k citations David E. Griffith, Timothy R. Aksamit et al. American Journal of Respiratory and Critical Care Medicine profile →
Adult Patients With Bronchiectasis

2016 251 citations Timothy R. Aksamit, Anne E. O’Donnell et al. CHEST Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy R. Aksamit United States	29	5.4k	3.7k	2.4k	1.6k	1.2k	90	6.9k
Won‐Jung Koh South Korea	56	8.3k 1.5×	6.8k 1.8×	3.6k 1.5×	2.1k 1.3×	2.2k 1.9×	352	11.1k
Theodore K. Marras Canada	32	3.4k 0.6×	2.3k 0.6×	1.4k 0.6×	721 0.4×	687 0.6×	118	4.1k
Ian F. Laurenson United Kingdom	25	1.9k 0.3×	1.2k 0.3×	564 0.2×	455 0.3×	620 0.5×	78	3.0k
Jeffrey Glassroth United States	28	2.6k 0.5×	2.0k 0.6×	469 0.2×	444 0.3×	641 0.5×	61	3.7k
Young Ae Kang South Korea	36	2.3k 0.4×	2.0k 0.5×	231 0.1×	1.0k 0.6×	1.4k 1.2×	262	4.8k
Diana Bilton United Kingdom	47	1.9k 0.3×	710 0.2×	379 0.2×	6.0k 3.7×	738 0.6×	199	7.9k
Ayman O. Soubani United States	28	1.4k 0.3×	1.2k 0.3×	234 0.1×	1.6k 1.0×	431 0.4×	145	3.4k
Mario Cruciani Italy	39	1.9k 0.4×	2.4k 0.6×	179 0.1×	263 0.2×	623 0.5×	156	4.7k
Sheldon T. Brown United States	34	2.1k 0.4×	1.7k 0.5×	91 0.0×	367 0.2×	446 0.4×	113	4.0k
Reşat Özaras Türkiye	31	1.2k 0.2×	749 0.2×	251 0.1×	224 0.1×	502 0.4×	155	3.1k

Countries citing papers authored by Timothy R. Aksamit

Since Specialization

Citations

This map shows the geographic impact of Timothy R. Aksamit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy R. Aksamit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy R. Aksamit more than expected).

Fields of papers citing papers by Timothy R. Aksamit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy R. Aksamit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy R. Aksamit. The network helps show where Timothy R. Aksamit may publish in the future.

Co-authorship network of co-authors of Timothy R. Aksamit

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy R. Aksamit. A scholar is included among the top collaborators of Timothy R. Aksamit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy R. Aksamit. Timothy R. Aksamit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monlezun, Dominique, Donald Kokonya, Timothy R. Aksamit, et al.. (2025). Digitalization of health care in low- and middle-income countries. Bulletin of the World Health Organization. 103(2). 148–154. 6 indexed citations

Pinheiro, Marina, Onno W. Akkerman, Timothy R. Aksamit, et al.. (2025). Consensus on the management of refractory nontuberculous mycobacterial pulmonary disease. European Respiratory Journal. 67(1). 2500400–2500400.

Aksamit, Timothy R., James D. Chalmers, Pierre‐Régis Burgel, et al.. (2024). LUNG FUNCTION IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS BY PRESPECIFIED SUBGROUPS IN THE PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED ASPEN TRIAL. CHEST Journal. 166(4). A6557–A6559. 3 indexed citations

Metersky, Mark L., Pierre‐Régis Burgel, Charles L. Daley, et al.. (2024). ANNUALIZED EXACERBATION RATE IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS BY PRESPECIFIED SUBGROUPS IN THE PH3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED ASPEN TRIAL. CHEST Journal. 166(4). A6554–A6556. 2 indexed citations

Aksamit, Timothy R., et al.. (2024). Association between bronchiectasis exacerbations and longitudinal changes in FEV1 in patients from the US bronchiectasis and NTM research registry. Respiratory Medicine. 228. 107660–107660.

Monlezun, Dominique, et al.. (2022). Artificial Intelligence-Augmented Propensity Score, Cost Effectiveness and Computational Ethical Analysis of Cardiac Arrest and Active Cancer with Novel Mortality Predictive Score. Medicina. 58(8). 1039–1039. 11 indexed citations

Díaz, Alejandro A., Pietro Nardelli, Wei Wang, et al.. (2022). Artificial Intelligence–based CT Assessment of Bronchiectasis: The COPDGene Study. Radiology. 307(1). e221109–e221109. 21 indexed citations

Ku, Jennifer H, Emily Henkle, Timothy R. Aksamit, et al.. (2022). Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines. Clinical Infectious Diseases. 76(2). 338–341. 19 indexed citations

Griffith, David E., Gina Eagle, Rachel Thomson, et al.. (2018). Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients. American Journal of Respiratory and Critical Care Medicine. 197. 1 indexed citations

10.

Winthrop, Kevin, Gina Eagle, Rachel Thomson, et al.. (2018). Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC). American Journal of Respiratory and Critical Care Medicine. 197.

11.

Aksamit, Timothy R., Anthony De Soyza, Tiemo-Joerg Bandel, et al.. (2018). RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. European Respiratory Journal. 51(1). 1702053–1702053. 126 indexed citations

12.

O’Donnell, Anne E. & Timothy R. Aksamit. (2018). 3rd World Bronchiectasis Conference. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 5(4). 302–323. 1 indexed citations

13.

Aksamit, Timothy R., Tiemo-Joerg Bandel, Margarita Criollo, et al.. (2017). The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis. Contemporary Clinical Trials. 58. 78–85. 27 indexed citations

14.

Soyza, Anthony De, Timothy R. Aksamit, Tiemo-Joerg Bandel, et al.. (2016). LATE-BREAKING ABSTRACT: RESPIRE 1: Ciprofloxacin DPI 32.5mg b.d. administered 14 day on/off or 28 day on/offvsplacebo for 48 weeks in subjects with non-cystic fibrosis bronchiectasis (NCFB). OA272–OA272. 3 indexed citations

15.

Aksamit, Timothy R., Anthony De Soyza, Elisabeth Operschall, Tiemo-Joerg Bandel, & Robert Wilson. (2015). A Comparison of Study Designs of Inhaled Agents in Non-Cystic Fibrosis Bronchiectasis (NCFB): Key Differences in the Phase 3 RESPIRE Trials of Ciprofloxacin Dry Powder for Inhalation (DPI). CHEST Journal. 148(4). 662A–662A. 1 indexed citations

16.

Aksamit, Timothy R., Julie V. Philley, & David E. Griffith. (2013). Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials. Respiratory Medicine. 108(3). 417–425. 78 indexed citations

17.

Allam, J. Shirine, Cassie C. Kennedy, Timothy R. Aksamit, & Angela Dispenzieri. (2008). Pulmonary Manifestations in Patients With POEMS Syndrome. CHEST Journal. 133(4). 969–974. 61 indexed citations

18.

Griffith, David E., Timothy R. Aksamit, Barbara A. Brown‐Elliott, et al.. (2007). An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. American Journal of Respiratory and Critical Care Medicine. 175(4). 367–416. 4257 indexed citations breakdown →

19.

Sauver, Jennifer L. St., Amy L. Weaver, Stephanie M. Bagniewski, et al.. (2004). Incidence of Tuberculosis in Olmsted County, Minnesota, 1990-2001. Mayo Clinic Proceedings. 79(9). 1119–1123. 3 indexed citations

20.

Aksamit, Timothy R.. (2001). Thromboembolism Occurrence and Diagnosis in the Medical Intensive Care Unit. Seminars in Thrombosis and Hemostasis. 27(1). 47–58. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact